SEARCH:   Advanced

Blood, 15 February 2007, Vol. 109, No. 4, pp. 1593-1601. Prepublished online as a Blood First Edition Paper on October 10, 2006; DOI 10.1182/blood-2006-05-025197. This Article Full Text Full Text (PDF) All Versions of this Article: blood-2006-05-025197v1 109/4/1593    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Renckens, R. Articles by van der Poll, T. Search for Related Content PubMed PubMed Citation Articles by Renckens, R. Articles by van der Poll, T. Related Collections Hemostasis, Thrombosis, and Vascular Biology Immunobiology Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  IMMUNOBIOLOGY Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia Rosemarijn Renckens1,2, Joris J. T. H. Roelofs3, Peter I. Bonta4, Sandrine Florquin3, Carlie J. M. de Vries4, Marcel Levi5, Peter Carmeliet6, Cornelis van't Veer1,2, and Tom van der Poll1,2 1 Center for Infection and Immunity Amsterdam, 2 Center for Experimental and Molecular Medicine, Departments of3 Pathology, 4 Biochemistry, and 5 Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands; 6 Center for Transgene Technology and Gene Therapy, University of Leuven, Belgium Plasminogen activator inhibitor type-1 (PAI-1) levels are consistently elevated in patients with severe pneumonia and sepsis and highly predictive for an unfavorable outcome. In addition, pneumonia is associated with strongly elevated PAI-1 levels in the pulmonary compartment. However, whether PAI-1 causally affects antibacterial host defense in vivo remains unknown. We report here that pneumonia caused by the common respiratory pathogen Klebsiella pneumoniae is associated with local production of PAI-1 in the lungs of wild-type mice. PAI-1 deficiency impaired host defense as reflected by enhanced lethality and increased bacterial growth and dissemination in mice with a targeted deletion of the PAI-1 gene. Conversely, transgenic overexpression of PAI-1 in the lung using a replication-defective adenoviral vector markedly improved host defense against Klebsiella pneumonia and sepsis. PAI-1 deficiency reduced accumulation of neutrophils in the lungs during pneumonia, whereas PAI-1 overexpression in healthy lungs resulted in neutrophil influx, suggesting that PAI-1 protects the host against Klebsiella pneumonia by promoting neutrophil recruitment to the pulmonary compartment. These data demonstrate for the first time that PAI-1 is essential for host defense against severe Gram-negative pneumonia. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll Inflammation, endothelium, and coagulation in sepsis J. Leukoc. Biol., March 1, 2008; 83(3): 536 - 545. [Abstract] [Full Text] [PDF]

	Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020